Publicacións en colaboración con investigadores/as de Hospital Infanta Sofia (19)

2024

  1. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting

    Diabetes care, Vol. 47, Núm. 2, pp. 216-224

  2. Exposure to different occupational chemicals and clinical phenotype of a cohort of patients with systemic sclerosis

    Autoimmunity Reviews

  3. Response to Comment on Beato-Víbora et al. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting. Diabetes Care 2024;47:216-224

    Diabetes care, Vol. 47, Núm. 5, pp. e46-e47

  4. Translating NIA-AA criteria into usual practice: Report from the ReDeMa Project

    Alzheimer's and Dementia: Translational Research and Clinical Interventions, Vol. 10, Núm. 1

2023

  1. Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry

    Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78

  2. Structural Similarities, in Relation with the Cross-Reactivity, of Hymenoptera Allergenic Dipeptidyl Peptidases IV—An Overall Comparison Including a New Dipeptidyl Peptidase IV Sequence from Vespa velutina

    Toxins, Vol. 15, Núm. 11

2022

  1. Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry

    European journal of preventive cardiology, Vol. 29, Núm. 6, pp. 859-868

  2. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. Effect of preoperative exercise on vascular caliber and maturation of arteriovenous fistula: the physicalfav trial, a randomized controlled study

    Journal of Nephrology, Vol. 34, Núm. 3, pp. 763-771

  3. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

    Research and Practice in Thrombosis and Haemostasis, Vol. 5, Núm. 1, pp. 168-178

2020

  1. Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry

    European heart journal, Vol. 41, Núm. 18, pp. 1720-1729

2019

  1. Quality standards for allergen immunotherapy clinics in Spain: Consensus document

    Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 4, pp. 272-279

2017

  1. Adding access blood flow surveillance reduces thrombosis and improves arteriovenous fistula patency: A randomized controlled trial

    Journal of Vascular Access, Vol. 18, Núm. 4, pp. 352-358

2016

  1. Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus

    Clinical and Experimental Rheumatology, Vol. 34, Núm. 3, pp. 466-472

  2. Systemic activity and mortality in primary Sjögren syndrome: Predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 2, pp. 348-355

  3. The impact of access blood flow surveillance on reduction of thrombosis in native arteriovenous fistula: A randomized clinical trial

    Journal of Vascular Access, Vol. 17, Núm. 1, pp. 13-19

2014

  1. Systemic involvement in primary Sjögren's syndrome evaluated by the EULAR-SS disease activity index: Analysis of 921 spanish patients (GEAS-SS registry)

    Rheumatology (United Kingdom), Vol. 53, Núm. 2, pp. 321-331

2009

  1. Learning and reliability of colour Doppler ultrasound in giant cell arteritis

    Clinical and Experimental Rheumatology, Vol. 27, Núm. 1 SUPPL. 52